Phase 1 Acute Respiratory Distress Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmCOVID-19 Infection+2 more

M.D. Anderson Cancer Center70 enrolled1 locationNCT04565665

Recruiting

Phase 1Phase 2

Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis

Acute Respiratory Distress Syndrome

PT. Prodia Stem Cell Indonesia15 enrolled1 locationNCT07439848

Recruiting

Phase 1Phase 2

A Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cell Injection for the Treatment of Severe Acute Respiratory Distress Syndrome

Acute Respiratory Distress Syndrome

Changchun Tuohua Pharmaceutical Co., Ltd.36 enrolled1 locationNCT07413978